Hymenochirin-1B

General Information


DRACP ID  DRACP02295

Peptide Name   Hymenochirin-1B

Sequence  IKLSPETKDNLKKVLKGAIKGAIAVAKMV

Sequence Length  29

UniProt ID  W8PRC4  W8NYW9 

PubChem CID  Not available

Origin  Hymenochirus boettgeri

Type  Native peptide

Classification

  

Active ACP Membrane lysis



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma LC50=2.5 ± 0.2 μM CellTiter-Glo Luminescent Cell Viability assay 24 h 1
MDA-MB-231 Breast adenocarcinoma Carcinoma LC50=9.0 ± 0.3 μM CellTiter-Glo Luminescent Cell Viability assay 24 h 1
HT-29 Colon adenocarcinoma Carcinoma LC50=9.7 ± 0.2 μM CellTiter-Glo Luminescent Cell Viability assay 24 h 1
HepG2 Hepatoblastoma Blastoma LC50=22.5 ± 1.4 μM CellTiter-Glo Luminescent Cell Viability assay 24 h 1
A549 Lung adenocarcinoma Carcinoma IC50=15.22±0.21 μM MTT assay 96 h 2
HCT 116 Colon carcinoma Carcinoma IC50=12.76±0.43 μM MTT assay 96 h 2
HepG2 Hepatoblastoma Blastoma IC50=8.07±0.21 μM MTT assay 96 h 2

Hemolytic Activity  Human erythrocytes: LC50=213 ± 18 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02295

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C139H251N37O37S

Absent amino acids  CFHQRWY

Common amino acids  K

Mass  356445

Pl  10.93

Basic residues  7

Acidic residues  2

Hydrophobic residues  13

Net charge  5

Boman Index  -1388

Hydrophobicity  16.9

Aliphatic Index  124.48

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 24185042

Title  Anti-tumor activities of the host-defense peptide hymenochirin-1B

Doi 10.1016/j.regpep.2013.10.006

Year  2013

Literature 2

Pubmed ID 30789695

Title  Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy

Doi 10.1021/acschembio.9b00046

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  DBAASPR_3785

DRACP is developed by Dr.Zheng's team.